Cost-effectiveness analysis of voriconazole versus amphotericin B in the treatment of invasive aspergillosis in Spain

被引：2
|
作者：
Grau, S
Mateu-de, AJ
Soto, J
Muñoz, M
Salas, E
机构：
[1] Univ Autonoma Barcelona, Hosp Mar, Dept Med, E-08003 Barcelona, Spain
[2] Pfizer SA, Madrid, Spain
来源：
VALUE IN HEALTH | 2003年 / 6卷 / 06期
关键词：
D O I：
10.1016/S1098-3015(10)61912-2
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
引用
收藏
页码：750 / 751
页数：2
相关论文
共 50 条
  • [41] Voriconazole - In the treatment of invasive aspergillosis
    Muijsers, RBR
    Goa, KL
    Scott, LJ
    DRUGS, 2002, 62 (18) : 2655 - 2664
  • [42] Treatment of disseminated aspergillosis with voriconazole/liposomal amphotericin B in a child with leukemia
    Athanassiadou, F
    Tragiannidis, A
    Kourti, M
    Papageorgiou, T
    Velegraki, A
    Kalogera, A
    PEDIATRIC BLOOD & CANCER, 2005, 45 (07) : 1003 - 1004
  • [43] Cost-effectiveness of amphotericin B formulations in the treatment of systemic fungal infections
    Lobo Borba, Helena Hiemisch
    Steimbach, Laiza Maria
    Riveros, Bruno Salgado
    Tonin, Fernanda Stumpf
    Ferreira, Vinicius Lins
    de Queiros Bagatim, Bruna Aline
    Balan, Gisele
    Pontarolo, Roberto
    Wiens, Astrid
    MYCOSES, 2018, 61 (10) : 754 - 763
  • [44] Efficacy and cost-effectiveness of voriconazole prophylaxis for prevention of invasive aspergillosis in high-risk liver transplant recipients
    Balogh, Julius
    Burroughs, Sherilyn Gordon
    Boktour, Maha
    Patel, Samir
    Saharia, Ashish
    Ochoa, Robert A.
    McFadden, Robert
    Victor, David W.
    Ankoma-Sey, Victor
    Galati, Joseph
    Monsour, Howard P., Jr.
    Fainstein, Victor
    Li, Xian C.
    Grimes, Kevin A.
    Gaber, A. Osama
    Aloia, Thomas
    Ghobrial, R. Mark
    LIVER TRANSPLANTATION, 2016, 22 (02) : 163 - 170
  • [45] Secondary resistance of invasive sinus aspergillosis to voriconazole and successful treatment with high dose liposomal amphotericin B.
    Burchardt, A
    Baurmann, H
    Mehdikhani, H
    Schwerdtfeger, R
    BLOOD, 2000, 96 (11) : 336B - 336B
  • [46] A COST-EFFECTIVENESS ANALYSIS OF PATIROMER FOR THE TREATMENT OF HYPERKALEMIA IN SPAIN
    Gonzalez-Juanatey, J. R.
    Gonzalez-Franco, A.
    de-Sequera-Ortiz, P.
    Valls, M.
    Serna, Ramirez de Arellano A.
    Pomares, E.
    Nieves, D.
    VALUE IN HEALTH, 2022, 25 (01) : S94 - S95
  • [47] Voriconazole for salvage treatment of invasive aspergillosis
    Schlamm, HT
    Corey, L
    Brown, J
    Perfect, JR
    CLINICAL INFECTIOUS DISEASES, 2000, 31 (01) : 265 - 265
  • [48] COST-EFFECTIVENESS ANALYSIS OF MICAFUNGIN VERSUS CASPOFUNGIN IN THE TREATMENT OF INVASIVE CANDIDA INFECTION IN CHINA
    Wang, C.
    Dong, H.
    Sun, L.
    VALUE IN HEALTH, 2014, 17 (03) : A275 - A276
  • [49] COST-EFFECTIVENESS OF CASPOFUNGIN VERSUS VORICONAZOLE FOR EMPIRIC THERAPY IN TURKEY
    Turner, S. J.
    Senol, E.
    Kara, A.
    Al-Badriyeh, D.
    Kong, D. C.
    Dinleyici, E. C.
    VALUE IN HEALTH, 2013, 16 (07) : A356 - A356
  • [50] ESTIMATING THE COST-EFFECTIVENESS OF ISAVUCONAZOLE FOR THE TREATMENT OF PATIENTS WITH POSSIBLE INVASIVE ASPERGILLOSIS IN THE UNITED KINGDOM
    Floros, L.
    Al Taie, A.
    Weidlich, D.
    Capparella, M. R.
    Charbonneau, C.
    Sung, A. H.
    VALUE IN HEALTH, 2018, 21 : S230 - S231
12345